1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Seizure in Participants With Tuberous Sclerosis Complex: new trials by email Literature Review of Seizure in Participants With Tuberous Sclerosis Complex trials Research Report on Seizure in Participants With Tuberous Sclerosis Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures GWP42003-P - Seizure in Participants With Tuberous Sclerosis Complex, Seizure in Participants With Dravet Syndrome | Phase 3 | Terminated | Jazz Pharmaceuticals | 3 | 2021-05-19 | 2025-10-31 |
Epilepsies, Myoclonic (1) · Epilepsy (1) · Lennox Gastaut Syndrome (1) · Seizures (1) · Spasms, Infantile (1) · Tuberous Sclerosis (1) · Tuberous Sclerosis 1 (1) · Tuberous Sclerosis 2 (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Epilepsy, Generalized (1) · Epileptic Syndromes (1) · Genetic Diseases, Inborn (1) · Hamartoma (1) · Heredodegenerative Disorders, Nervous System (1) · Malformations of Cortical Development (1) · Malformations of Cortical Development, Group I (1) · Neoplasms (1) · Neoplasms, Multiple Primary (1) · Neoplastic Syndromes, Hereditary (1) · Nervous System Diseases (1)
Cannabidiol (1)
Italy (1) · Spain (1) · United States (1)